Column Group’s Revolution Medicines RVMD Stock Holding History
Bought
  Maintained
  Sold
  | Quarter | Market Value | Status | Shares | 
        
          
          
            Change in  Stake  | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
| 
        
          
      
        2025
         Q2  | $1.69K | Hold | 
         | 
    |||||
| 
        
          
      
        2025
         Q1  | $1.63K | Hold | 
         | 
    |||||
| 
        
          
      
        2024
         Q4  | $2.09K | Hold | 
         | 
    |||||
| 
        
          
      
        2024
         Q3  | $2.09K | Hold | 
         | 
    |||||
| 
        
          
      
        2024
         Q2  | $1.78K | Hold | 
         | 
    |||||
| 
        
          
      
        2024
         Q1  | $1.48K | Hold | 
         | 
    |||||
| 
        
          
      
        2023
         Q4  | $1.32K | Sell | 
         | 
    |||||
| 
        
          
      
        2023
         Q3  | $34.1M | Sell | 
         | 
    |||||
| 
        
          
      
        2023
         Q2  | $68.9M | Sell | 
         | 
    |||||
| 
        
          
      
        2023
         Q1  | $99.2M | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q4  | $109M | Hold | 
         | 
    |||||
| 
        
          
      
        2022
         Q3  | $90.3M | Buy | 
         | 
    |||||
| 
        
          
      
        2022
         Q2  | $85.7M | Buy | 
         | 
    |||||
| 
        
          
      
        2022
         Q1  | $85.4M | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q4  | $84.3M | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q3  | $92.1M | Hold | 
         | 
    |||||
| 
        
          
      
        2021
         Q2  | $106M | Sell | 
         | 
    |||||
| 
        
          
      
        2021
         Q1  | $164M | Hold | 
         | 
    |||||
| 
        
          
      
        2020
         Q4  | $142M | Buy | 
         |